National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

asparaginase-Erwinia
An enzyme isolated from the bacterium Erwinia chrysanthemi (E. carotovora). Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting leukemic cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle. This agent also induces apoptosis in tumor cells. The Erwinia-derived product is often used for those patients who have experienced a hypersensitivity reaction to the E. Coli formulation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:crisantaspasum
cristantaspase
Erwinia L-asparginase
krisantaspaasi
krisantaspas
Foreign brand name:Erwinase



Previous:ascorbic acid, ashwagandha root powder extract, ASONEP, Asorbicap, asparaginase
Next:asulacrine isethionate, Atacand, atamestane, ATGAM, Athrombin-K

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov